The first clinical-stage dual-payload conjugate
Chengdu Kanghong's KH815 enters human testing this month.
Interest builds in a new synthetic lethality story
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
Chengdu Kanghong's KH815 enters human testing this month.
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
